Elmira

Pleased to share our latest Mendelian randomization study on #adiposity and #headandneck #cancer 🧬🗣🎗 is now available on @medrxivpreprint

I’m excited to share a major milestone in my PhD progress! 🚀 We’ve identified a TP53 variant (rs78378222) in the 3’ UTR that reduces the risk of developing HNSCC by 40%—a huge finding in cancer genetics! Read the full preprint here: medrxiv.org/content/10.110… #CancerResearch

Cross-ancestral GWAS identifies 29 novel variants across Head and Neck Cancer subsites medrxiv.org/cgi/content/sh… #medRxiv

@tinauchojo @IARCWHO @HEADSpAcE_Study @ECSA_IARC Thank you dear @tinauchojo

@ellvlirae @IARCWHO @HEADSpAcE_Study @ECSA_IARC Congratulations Elmira

Just had an incredible time at #ESHG2023 conference! It was such a great atmosphere with groundbreaking research and inspiring discussions. Learned so much from the brilliant minds in genetics. @IARCWHO @HEADSpAcE_Study @ECSA_IARC

#HPV might cause 1 in 5 cases of #prostate cancer, analysis says upi.com/7021709t

A new pre-print study led by @kingsmedicine has found that characteristic skin rashes can occur in the absence of any other symptoms, and could be considered key diagnostic signs of the virus. #WeareKings @lifecourse_KCL @TwinsUKres kcl.ac.uk/news/skin-rash…